Signaturefd, LLC Roivant Sciences Ltd. Transaction History
Signaturefd, LLC
- $5.2 Billion
- Q3 2024
A detailed history of Signaturefd, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Signaturefd, LLC holds 426 shares of ROIV stock, worth $5,410. This represents 0.0% of its overall portfolio holdings.
Number of Shares
426
Previous 322
32.3%
Holding current value
$5,410
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ROIV
# of Institutions
311Shares Held
508MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$837 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$836 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$687 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$529 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$449 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.95B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...